Craig Skinner

Scientist at DICE Therapeutics

Craig Skinner has a diverse background in research, with experience in various scientific roles. Craig started their career at UCSF as a Research Associate I, where they maintained mouse colonies, performed genotyping, and conducted histology work. Craig then transitioned to Maxygen, Inc as a Research Associate I, contributing to the development of an aerosol vaccine against the plague and anthrax. Craig later pursued a graduate degree at UC Davis, where they worked as a Graduate Student Researcher, focusing on yeast lifespan and the mediation of calorie restriction and longevity. Following this, they joined USDA-WRRC as a Research Molecular Biologist, specializing in the purification of Shiga-like toxins and the generation of His-tagged Stx2 subunits. Craig currently works at DiCE Molecules as a Scientist, although specific details of their role are not provided. Overall, Craig Skinner's work experience showcases their expertise in molecular biology, biochemistry, and research in various fields.

Craig Skinner has a strong educational background in the field of Biochemistry and Molecular Biology. Craig completed their Bachelor of Science degree in Biochemistry/Cell biology at the University of California, Berkeley, from 1995 to 1999. Building upon this foundation, they pursued their academic career and obtained a Doctor of Philosophy degree in Biochemistry and Molecular Biology from the same institution, completing their studies from 2005 to 2011.

Links

Timeline

  • Scientist

    April, 2016 - present